The pharmacology of leishmaniasis
- PMID: 9580315
- DOI: 10.1016/s0306-3623(97)00268-1
The pharmacology of leishmaniasis
Abstract
The development of new strategies on chemotherapy of parasitic protozoan diseases is one of the most exciting research fields of recent years. World Health Organization (WHO) reports have recognized that the physiology and biochemistry of protozoan parasites and the host-parasite relation are the main targets for the design of new drugs that can be used in the future against these diseases.
Similar articles
-
Leishmaniasis: some recent developments in chemotherapy.J Antimicrob Chemother. 1993 Mar;31(3):327-30. doi: 10.1093/jac/31.3.327. J Antimicrob Chemother. 1993. PMID: 8486567 No abstract available.
-
Leishmaniasis.Nat Rev Microbiol. 2004 Sep;2(9):692. doi: 10.1038/nrmicro981. Nat Rev Microbiol. 2004. PMID: 15378809 No abstract available.
-
Advancement in leishmaniasis diagnosis and therapeutics: An update.Eur J Pharmacol. 2021 Nov 5;910:174436. doi: 10.1016/j.ejphar.2021.174436. Epub 2021 Aug 21. Eur J Pharmacol. 2021. PMID: 34428435 Review.
-
Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.J Liposome Res. 2017 Sep;27(3):234-248. doi: 10.1080/08982104.2017.1376682. Epub 2017 Sep 26. J Liposome Res. 2017. PMID: 28874072 Review.
-
Rational approaches for drug designing against leishmaniasis.Appl Biochem Biotechnol. 2010 Apr;160(8):2208-18. doi: 10.1007/s12010-009-8764-z. Epub 2009 Sep 8. Appl Biochem Biotechnol. 2010. PMID: 19756413 Review.
Cited by
-
Leishmaniasis: where are we and where are we heading?Parasitol Res. 2021 May;120(5):1541-1554. doi: 10.1007/s00436-021-07139-2. Epub 2021 Apr 7. Parasitol Res. 2021. PMID: 33825036 Review.
-
Impact of Marasmic Malnutrition on Visceral Leishmaniasis: Progression and Treatment Efficacy in a Murine Model.Nutrients. 2025 Feb 28;17(5):849. doi: 10.3390/nu17050849. Nutrients. 2025. PMID: 40077719 Free PMC article.
-
Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.Int J Parasitol Drugs Drug Resist. 2014 Aug 24;4(3):326-37. doi: 10.1016/j.ijpddr.2014.07.006. eCollection 2014 Dec. Int J Parasitol Drugs Drug Resist. 2014. PMID: 25516844 Free PMC article. Review.
-
Total synthesis and antileishmanial activity of the natural occurring acetylenic fatty acids 6-heptadecynoic acid and 6-icosynoic acid.Lipids. 2009 Oct;44(10):953-61. doi: 10.1007/s11745-009-3345-z. Epub 2009 Sep 30. Lipids. 2009. PMID: 19789903 Free PMC article.
-
Indotecan (LMP400) and AM13-55: two novel indenoisoquinolines show potential for treating visceral leishmaniasis.Antimicrob Agents Chemother. 2012 Oct;56(10):5264-70. doi: 10.1128/AAC.00499-12. Epub 2012 Jul 30. Antimicrob Agents Chemother. 2012. PMID: 22850521 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical